Ausgabe 1/2011
Inhalt (5 Artikel)
Open Access
Case Report
Clinical consequences of reduced dosing schedule during treatment of a patient with Pompe’s disease
Emilia Barrot Cortés, Juana María Barrera Chacón
Open Access
Review
New Frontiers in Subcutaneous Immunoglobulin Treatment
Stephen Jolles, Mark R. Stein, Hilary J. Longhurst, Michael Borte, Bruce Ritchie, Matthias H. Sturzenegger, Melvin Berger
Open Access
Original Research
Effect of switching recombinant human growth hormone: Comparative analysis of phase 3 clinical data
Tomasz Romer, Markus Zabransky, Mieczyslaw Walczak, Mieczyslaw Szalecki, Sigrid Balser